Note E - CB Oncology Partners (Tables)

6 Months Ended

Jun. 30, 2024

CB Oncology Partners ("CBOP") [Member]

Notes Tables

Equity Method Investments [Table Text Block]

	Six Months Ended
	2024			2023
Patient revenue	$	584,000		$	761,000
Net (loss) income	$	(761,000	)	$	(607,000	)
USNC's equity in (loss) income of CBOP	$	(230,000	)	$	(173,000	)

	June 30,			December 31,
	2024			2023
Current assets	$	262,000		$	116,000
Noncurrent assets		2,084,000			2,381,000
Total assets	$	2,346,000		$	2,497,000
Current liabilities	$	4,048,000		$	4,150,000
Noncurrent liabilities		3,594,000			2,882,000
Deficit		(5,296,000	)		(4,535,000	)
Total liabilities and deficit	$	2,346,000		$	2,497,000